Alissa Lim1, Noel Cranswick, Michael South. 1. Department of General Medicine, Royal Children's Hospital, Parkville, Melbourne, Australia. alissa.lim@rch.org.au
Abstract
OBJECTIVE: To determine the types of adverse events associated with the use of complementary and alternative medicine (CAM) that come to the attention of Australian paediatricians. DESIGN: Monthly active surveillance study of CAM-associated adverse events as reported to the Australian Paediatric Surveillance Unit between January 2001 and December 2003. RESULTS: There were 39 reports of adverse events associated with CAM use, including four reported deaths. Reports highlighted several areas of concern, including the risks associated with failure to use conventional medicine, the risks related to medication changes made by CAM practitioners and the significant dangers of dietary restriction. The reported deaths were associated with a failure to use conventional medicine in favour of a CAM therapy. CONCLUSION: CAM use has the potential to cause significant morbidity and fatal adverse outcomes. The diversity of CAM therapies and their associated adverse events demonstrate the difficulty addressing this area and the importance of establishing mechanisms by which adverse effects may be reported or monitored.
OBJECTIVE: To determine the types of adverse events associated with the use of complementary and alternative medicine (CAM) that come to the attention of Australian paediatricians. DESIGN: Monthly active surveillance study of CAM-associated adverse events as reported to the Australian Paediatric Surveillance Unit between January 2001 and December 2003. RESULTS: There were 39 reports of adverse events associated with CAM use, including four reported deaths. Reports highlighted several areas of concern, including the risks associated with failure to use conventional medicine, the risks related to medication changes made by CAM practitioners and the significant dangers of dietary restriction. The reported deaths were associated with a failure to use conventional medicine in favour of a CAM therapy. CONCLUSION: CAM use has the potential to cause significant morbidity and fatal adverse outcomes. The diversity of CAM therapies and their associated adverse events demonstrate the difficulty addressing this area and the importance of establishing mechanisms by which adverse effects may be reported or monitored.
Authors: P Marchisio; M Santagati; M Scillato; E Baggi; M Fattizzo; C Rosazza; S Stefani; S Esposito; N Principi Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-18 Impact factor: 3.267
Authors: Miek C Jong; Marja van Vliet; Susan Huttenhuis; Désirée van der Veer; Silvia van den Heijkant Journal: BMC Complement Altern Med Date: 2012-01-16 Impact factor: 3.659
Authors: Esther I Feijen-de Jong; Danielle E M C Jansen; Frank Baarveld; Evelien Spelten; François Schellevis; Sijmen A Reijneveld Journal: BMC Pregnancy Childbirth Date: 2015-06-25 Impact factor: 3.007
Authors: Lisa Strouss; Amy Mackley; Ursula Guillen; David A Paul; Robert Locke Journal: BMC Complement Altern Med Date: 2014-03-04 Impact factor: 3.659